Articles by James Calloway
Intel Surges on AI Server Profit Surge; 79% Incremental Margin
Intel shares rose nearly 4% premarket after Q2 earnings beat, driven by a 79% incremental margin in data-center and AI revenue, which surged 59%.
American Airlines Shares Dive 8% as Fuel Costs Swallow Revenue Gains
American Airlines shares tumbled 8% after fuel expenses ate up nearly all of its revenue increase, leading to a sharply reduced profit forecast.
Blackstone Q2 Earnings Beat on AI-Driven Real Estate Gains
Blackstone's Q2 distributable earnings surged 26% to $1.98B, topping forecasts, fueled by AI-related asset sales in real estate, while private credit faced headwinds.
MaxLinear Stock Dips 11% Despite Q3 Guidance Beat
MaxLinear (MXL) dropped 11.2% after hours despite Q3 revenue guidance of $215 million, beating estimates by 23.6% and showing strong margin improvement.
Deckers Outdoor Shares Slide as Buybacks Support EPS Amid Profit Decline
Deckers Outdoor (NYSE:DECK) shares dropped 6.1% in after-hours trading after reporting a 6.6% decline in net income, though EPS increased due to aggressive share buybacks.
Martha Stewart Lamp at Marshalls Highlights TJX Home Segment Growth
TJX's HomeGoods segment reported a 40% jump in operating profit, with sales up 11%. A $70 Martha Stewart lamp at Marshalls illustrates the company's home goods appeal and margin growth.
ServiceNow Shares Slide 3.7% on Weaker H2 Forecast
ServiceNow shares dropped 3.7% after its 2026 forecast suggested softer H2 performance, with subscription revenue $44.5 million below earlier projections.
Intel Smashes Q2 Estimates on AI Server Strength, Shares Surge
Intel's Q2 earnings beat expectations thanks to robust AI server profits, with revenue and EPS surpassing estimates. Shares climbed 5% after-hours.
M&T Bank Boosts Borrowing to Fuel Loan Growth Amid Record Earnings
M&T Bank posted record quarterly earnings but turned to borrowings to fund loan growth as deposits fell. Shares slipped 2.2%.
FDA Panel Backs BPC-157 Compounding; Hims & Hers Surges
Hims & Hers shares gained 6.4% after FDA advisers voted to recommend BPC-157 for compounding, a move that could open a new U.S. sales channel.
NovoCure Jumps 29% on Record Sales, Raised 2026 Guidance
NovoCure shares surged 29% on record Q2 sales and a raised 2026 outlook, with revenue topping consensus by 6.5% and adjusted EBITDA turning positive.
